Naos, the dermo-cosmetics group, announces the appointment of Frédéric Ennabli as chairman of the management board, effective January 12, 2026. With more than twenty years’ experience as a business leader, he has been managing director of Pierre Fabre Dermo-Cosmétique (a division of the Pierre Fabre Group, editor’s note) since 2022.
Frédéric Ennabli to join the Naos group. – DR
He will step down from these duties before taking up his new role in early 2026. He previously served as managing director of YellowKorner (2014–2021), The Body Shop (2010–2013), and Club des Créateurs de Beauté (2007–2010). Earlier in his career, he worked at L’Oréal, where he headed the Swiss subsidiary.
His career, spanning niche brands and international groups, has enabled him to develop expertise in product innovation, digital transformation, and distribution strategy. According to the Naos press release announcing his appointment at Pierre Fabre, he led a far-reaching transformation that restored momentum and helped the company regain market share in a highly competitive environment.
This appointment comes at a time of sustained development for Naos. The group, parent company of Bioderma, Institut Esthederm, and Etat Pur brands, posted revenue of €896 million in 2024 and aims to surpass the €1 billion mark by 2026. The company, which has recorded double-digit average annual growth over the past decade, is also expanding its industrial base in Aix-en-Provence. It recently finalized the acquisition of Probionat, a supplier of natural cosmetics, to bring its production capacity in-house and better meet rising global demand.
Jean-Noël Thorel, who founded the group, has appointed Laurent Marteau to lead its transitional management, effective September 1. At the same time, Thorel continues to serve as chairman of the group’s strategic orientation and supervisory committee.
Frédéric Ennabli is expected to bring his experience in international markets and his ability to transform organizations to Naos.
This article is an automatic translation. Click here to read the original article.
